Business
NuGen Provides 2021 Year in Review and 2022 Corporate Update
Toronto, Ontario--(Newsfile Corp. - January 12, 2022) - NuGen Medical Devices Inc. (TSXV: NG...
About this update from Nugen Medical Devices Inc
[{"type":"text","content":"NuGen Provides 2021 Year in Review and 2022 Corporate UpdateToronto, Ontario--(Newsfile Corp. - January 12, 2022) - NuGen Medical Devices Inc. (TSXV: NGMD) (\"NuGen\" or the \"Company\") is pleased to provide an overview of its 2021 accomplishments and its corporate objectives for 2022. NuGen would first like to thank our shareholders for their continued support as the Company completed the Qualifying Transaction and achieved its public listing on the TSX Venture Exchange (the \"Listing\"). The Company is working towards its objectives of becoming the global leader of needle-free injection technology while the Company navigated a longer than expected listing timeline. Medical injections are a common healthcare procedure and the demand for a needle-free delivery solutions are increasing to improve safety and drug effectiveness, while lowering costs and reducing medical waste of disposable needles. It also helps reduce the fears and anxiety of administering medications and vaccines through hypodermic needles. 2021 was a year of building the necessary infrastructure to position NuGen for success in 2022 and beyond. This included financing, appointing additional management, directors and advisors, securing its manufacturing, building out the supply chain, and advancing distribution and sales agreements while seeking regulatory approval in North America for its needle-free injection system, also known as InsuJet™.Nugen's needle-free injection system is the first ever self-administered needle-free injection system approved by Health Canada and gives access to safe, cost-effective drug delivery for the millions of patients who suffer from diabetes or other chronic illnesses.It is specifically designed for the safety of patients who are required to self-administer their medication as well as health care workers who perform medical injections. The Company's needle-free injector is not only suitable for administering insulin, vaccines and other treatments for chronic diseases but also for pets requiring medical injections.2021 Accomplishments:Commenced trading on November 8th, 2021, under the symbol \"NGMD\" on the TSX Venture Exchange;Received a substantial investment from appointed director Michael Wekerle, an investor on the Canadian reality show Dragon's Den, Ex-Vice Chairman of GMP Securities and one of the key figures in the ...